Conference on Cell and Gene Therapy for HIV Cure 2014

August 26-27, 2014

Fred Hutchinson Cancer Research Center

Seattle, WA USA

defeatHIV, in collaboration with the Fred Hutchinson Cancer Research Center, the University of Washington Center for AIDS Research (UW CFAR) and the UW Virology Division, will host its inaugural Conference on Cell and Gene Therapy for HIV Cure in Seattle, WA on August 26-27 2014. The event will be held on the campus of the Fred Hutchinson Cancer Research Center. Born out of the desire to bring much needed attention to HIV cell and gene therapies, this conference aims to unite an international roster of esteemed scientists to share and discuss novel treatments and research using these innovative modalities.

Keynote Speaker

Photo FBS - HR01

2008 Nobel Prize Laureate, Medicine

Dr. Françoise BARRÉ-SINOUSSI is the Director of the “Regulation of Retroviral Infections” Unit in the Department of Virology at the Institut Pasteur in Paris. She has been involved in retrovirology research since the early 1970′s and is widely recognized for her contributions to HIV/AIDS research, in particular in the discovery of HIV. The research programs of her team are focused on mechanisms required to protect against HIV/SIV infections and/or against early pathogenic signals induced by HIV/SIV. CGT4HIVCURE 2014 Speakers

CGT Conference Updates

August 18, 2014: Dinner & Reception page posted
August 18, 2014:   Open to the public –  Community Event on 8/27 (Day 2) featuring Françoise Barré–Sinouissi.  Event details here.
August 15, 2014: Final Conference Agenda posted.
August 13, 2014: Updated Speakers page posted.
July 18, 2014:
  The Scholarship Application window has now closed.
June 25, 2014:  Conference hotel room blocks extended! See Registration & Lodging page for details.
June 5, 2014:  Scholarship deadline extended! See Important Dates and Scholarships pages for details.
May 22, 2014: 
New Important Dates posted
May 12, 2014:  Approaching Deadline: Scholarship applications due May 30, 2014

This conference is made possible by the generous support of the following companies:









Miltenyi Biotech

Sigma Aldrich